José E. Almeida

José E. Almeida (born 1961 or 1962) is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016.[1][2] He also serves on the board of directors of the Advanced Medical Technology Association (AdvaMed) and Partners in Health, and he is a member of Business Roundtable.[3]

Career

Almeida worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011.[4] He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.[5] He became a director of EMC Corporation on Jan 12, 2015[6] and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter International.[7]

In 2023, Almeida's total compensation at Baxter International was $13.8 million.[8]

Education

A native of Brazil, Almeida received a Bachelor of Science in mechanical engineering from Instituto Mauá de Tecnologia in São Paulo.[1]

References

  1. ^ a b Hoffman, Liz; Lublin, Joann S. (2015-10-28). "Baxter International Hires Outsider José Almeida as CEO". Wall Street Journal. ISSN 0099-9660. Retrieved 2018-08-28.
  2. ^ "José E. Almeida: Executive Profile & Biography – Bloomberg". www.bloomberg.com. Retrieved 2018-07-16.
  3. ^ "Business Roundtable Members" (PDF). content.influencemap.org.
  4. ^ "Covidien Plc (COV:New York)". Bloomberg Businessweek. Retrieved 18 February 2014.
  5. ^ "The Carlyle Group Names José E. Almeida Operating Executive for Global Healthcare Team | The Carlyle Group". The Carlyle Group. May 4, 2015. Retrieved May 8, 2016.
  6. ^ "EMC Expands Board of Directors with Appointment of José E. Almeida and Donald J. Carty". EMC Corporation. January 12, 2015.
  7. ^ "EMC Corporation – Investor Relations – Financials – SEC Filings – SEC Filings Details" (Press release). EMC Corporation. November 2, 2015.
  8. ^ Anderson, Sarah (2024-08-29). "Executive Excess 2024: The "Low Wage 100" corporations are enriching CEOs at the expense of workers and long-term investment" (PDF). Institute for Policy Studies. Archived (PDF) from the original on 2024-08-29. Retrieved 2024-08-31.